Skip to main content
OpenTrials

Clinical trial condition

Muscular Dystrophy, Facioscapulohumeral

Explore clinical trials studying Muscular Dystrophy, Facioscapulohumeral. Study availability and eligibility vary by location and protocol.

15 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Muscular Dystrophy, Facioscapulohumeral trial results

Recruiting

Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1

NCT06131983

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +6 more
Locations
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Wesley Research Institute Auchenflower, Queensland, Australia
  • Sunshine Coast University Hospital Birtinya, Queensland, Australia
  • Alfred Health Melbourne, Victoria, Australia
View all 16 locations
View Trial Details
Recruiting

Clenbuterol to Target DUX4 in FSHD

NCT06721299

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +6 more
Locations
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • University of Washington Seattle, Washington, United States
View Trial Details
Recruiting

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

NCT06847282

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +6 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Rochester Rochester, New York, United States
View Trial Details
Active, not recruiting

Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT06547216

Conditions
Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of California San Diego San Diego, California, United States
  • University of Colorado Denver, Colorado, United States
View all 17 locations
View Trial Details
Completed

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT05747924

Conditions
Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of California San Diego San Diego, California, United States
  • University of Colorado Denver, Colorado, United States
View all 17 locations
View Trial Details

Related conditions